Currently out of the existing stock ratings of Jayson Bedford, 252 are a BUY (96.18%), 10 are a HOLD (3.82%).

Jayson Bedford

Work Performance Price Targets & Ratings Chart

Analyst Jayson Bedford, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 61.85% that have a potential upside of 17.91% achieved within 247 days.

Jayson Bedford’s has documented 520 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 06-Jan-2026.

Wall Street Analyst Jayson Bedford

Analyst best performing recommendations are on SENS (SENSEONICS HOLDINGS).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/5/2020. The price target of $85 was fulfilled within 9 days with a profit of $10.69 (14.39%) receiving and performance score of 15.98.

Average potential price target upside

of $52.03 (18.92%) on ISRG (INTUITIVE SURGICAL).
of $31.95 (14.71%) on PODD (INSULET).
of $29.83 (21.22%) on JNJ (JOHNSON & JOHNSON).

ABT Abbott Laboratories ANGO AngioDynamics BAX Baxter International BSX Boston Scientific Corp BWAY Brainsway Ltd DXCM DexCom EW Edwards Lifesciences Corp HOLX Hologic ICUI ICU Medical ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic PLC MMSI Merit Medical Systems PODD Insulet SENS Senseonics Holdings TNDM Tandem Diabetes Care TFX Teleflex MASI Masimo NVTR Nuvectra ZBH Zimmer Biomet Holdings BDX Becton Dickinson and Company AXGN Axogen

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joanne Wuensch (CITI)